Announcement on Major Litigation

Guangzheng Ophthalmology Co., Ltd.·August 5, 2026·2 pages

✨ AI Summary

Guangzheng Ophthalmology's subsidiary, Guangzheng Construction, is suing Nantong Sizhi for unpaid engineering fees totaling 26.26 million RMB. The case is in its first instance, with no hearing yet. The outcome's impact on the company's financials is currently unassessable.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Guangzheng Ophthalmology Group Co., Ltd.

Stock Code: 002524 Stock Abbreviation: Guangzheng Ophthalmology Announcement No.: 2026-047

Announcement on Major Litigation

The Company and all members of the Board of Directors guarantee the content of the information disclosure is true, accurate, and complete, and there are no false records, misleading statements, or major omissions.

Special Reminder:

Litigation stage: First instance has not yet opened.
Party status of the listed company: The wholly-owned subsidiary, Guangzheng Construction Group Co., Ltd., is the plaintiff.
Amount involved: 26.26 million RMB.
Impact on the listed company's profits and losses: This case has not yet been heard in the first instance, and the impact of this litigation on the company's financial situation, current period profit, or subsequent period profit cannot be assessed at this time.

I. Basic Situation of the Case

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.